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Edited by Ulrike KutayAbstract Arc1p, a yeast tRNA-binding protein, forms a com-
plex with the aminoacyl-tRNA synthetases, methionyl tRNA
synthetase (MetRS) and glutamyl tRNA synthetase (GluRS).
Although this complex localizes normally in the cytoplasm, in
the absence of Arc1p the two free synthetases are also found in-
side the nucleus. In this work, in order to localize free Arc1 we
abolished complex assembly by deleting the appended domains
from both MetRS and GluRS. Surprisingly, free Arc1p re-
mained cytoplasmic even when ﬁtted with a strong nuclear local-
ization signal (NLS). However, NLS-Arc1p accumulated in the
nucleus when Xpo1/Crm1, the export receptor for NES-contain-
ing cargo proteins, was mutated. Thus, the cytoplasmic location
of Arc1p is maintained by Xpo1p-dependent nuclear export and
Arc1p could act as an adapter in the nucleocytoplasmic traﬃck-
ing of tRNA and/or the tRNA-aminoacylation machinery.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Aminoacylation of tRNA is a critical step in the decoding of
the genetic information and its ﬁdelity is very important for the
faithfulness of translation. This process is catalyzed by amino-
acyl-tRNA synthetases, a group of 20 diﬀerent enzymes, one
for each amino acid, with conserved catalytic domains [1].
Aminoacyl-tRNA synthetases have also been shown to play
a role in nucleocytoplasmic transport since tRNA-aminoacyla-
tion is necessary for the eﬃcient nuclear export of tRNA both
in vertebrates and yeast [2–4]. These results have suggested the
presence of the tRNA-aminoacylation machinery inside the
nucleus, which has also been substantiated by experimental
data [5–7]. However, the means of controlling the distribution
of aminoacyl-tRNA synthetases between cytoplasm and nu-
cleus is essentially unknown.Abbreviations: MetRS, methionyl tRNA synthetase; GluRS, glutamyl
tRNA synthetase; TRBD, tRNA binding domain; GFP, green ﬂuo-
rescent protein; NLS, nuclear localization signal; LMB, leptomycin B;
ORF, open reading frame
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doi:10.1016/j.febslet.2004.11.112Another characteristic of eukaryotic aminoacyl-tRNA
synthetases is their ability to form macromolecular complexes.
All metazoan have indeed been shown to contain a multi-
enzyme complex comprising nine aminoacyl-tRNA syntheta-
ses and three non-catalytic polypeptides, p43 (pro-EMAPII),
p38 and p18 [8,9]. The cytosolic and nuclear forms of this
complex have been recently isolated from human cells and
shown to have very similar polypeptide composition, stoichi-
ometry and three-dimensional structure [10].
We previously identiﬁed in yeast a smaller complex of ami-
noacyl-tRNA synthetases consisting of methionyl-tRNA syn-
thetase (MetRS), glutamyl-tRNA synthetase (GluRS) and
the non-catalytic protein Arc1p [11]. The association of Arc1p
with the two enzymes is mediated by its amino-terminal do-
main, which shows sequence similarity to both p18 and p38
and harbours overlapping binding sites for the amino-termi-
nally appended non-catalytic domains of the synthetases [12].
Formation of the trimeric Arc1p–MetRS–GluRS complex
stimulates the catalytic eﬃciency of both enzymes [13,14]. This
stimulation is mainly due to the increased aﬃnity of the com-
plex for the cognate tRNAs and requires the carboxy-terminal
part of Arc1p, which harbours a tRNA-binding domain
(TRBD) that is conserved in p43 as well as other proteins
[15,16]. Arc1p is required for optimal cell growth and becomes
essential for viability in the absence of the tRNA nuclear ex-
port factor Los1p [11,17] suggesting a possible involvement
of the Arc1p-complex in the transport of tRNA. In addition,
recent data suggest that Arc1p can facilitate tRNA-aminoacy-
lation in vivo independently of its ability to interact physically
with GluRS and MetRS and this function can also be provided
to the yeast cell by p43, the human homologue of Arc1p [18].
Mammalian p43 has been previously localized in both the
cytoplasmic and nuclear compartments [10,19]. In contrast,
yeast Arc1p has been shown to have an exclusive cytoplasmic
localization [11,12]. However, mutant forms of Arc1p, that
carried deletions in the amino-terminal domain and were un-
able to associate with the two synthetases, could also be de-
tected inside the yeast nucleus [12]. Similarly, MetRS and
GluRS could only be detected inside the nucleus when the for-
mation of the Arc1p–MetRS–GluRS complex was inhibited
[12]. It, therefore, appeared probable that the interaction be-
tween Arc1p and the appended non-catalytic domains of the
synthetases was responsible for tethering Arc1p and/or the
synthetases to the cytoplasm.
In this work and in order to study further the subcellular
dynamics of Arc1p, we constructed a yeast strain in which
the aminoterminal domains of both MetRS and GluRS wereblished by Elsevier B.V. All rights reserved.
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mic even when fused to a strong nuclear localization signal. By
these as well as other experiments, we conclude that Arc1p is
maintained in the cytoplasm by active nuclear export mediated
by the exportin Xpo1p/Crm1.2. Materials and methods
2.1. Yeast strains, media and plasmids
The following yeast strains have been previously described: RS453,
arc1 and arc1 los1 [11], mes1 and gus1 [12], MNY7 and
MNY8 [20], xpo1-1 [21,22], sub2 [23]. For counter selection of cells
containing URA3 plasmids, 5-ﬂuoroorotic acid (5-FOA, Toronto Re-
search Chem.) was used at 1 lg/ml. The following previously described
plasmids were used: pUN100 (CEN/ARS, LEU2) [24]; pRS314 (CEN/
ARS, TRP1), pASZ11-PNOP1-green ﬂuorescent protein (GFP) [12],
pPNOP1-GFPA1A-SUB2 [23], YEp13-L25-lacZ [25], pRS313-XPO1
and pRS313-xpo1-1 [22]. Cloning and tagging of GluRS and MetRS
by ProtA as well as the construction of plasmids expressing ProtA
and GFP-tagged truncated forms of MetRS, GluRS and Arc1p were
described previously [12].
2.2. Construction of NLS- and Sub2p fusion proteins
For construction of plasmids expressing nuclear localization signal
(NLS)-GFP tagged forms of Arc1 and its mutant forms, ProtA-Arc1
was ampliﬁed as a BamHI–KpnI fragment from plasmid pUN100-Pro-
tA-Arc1 [11] and inserted into the pRS314 vector (BamHI–KpnI). The
RPL25 promoter (433 nucleotides upstream of start codon) plus the
NLS-containing sequence (nucleotides 1–564 containing the ﬁrst intron
and encoding for the ﬁrst 49 amino acids of the Rpl25 protein) was ex-
cised from plasmid YEp13-L25-lacZ as a BamHI fragment and in-
serted into plasmid pRS314-ProtA-Arc1 (BamHI), creating plasmid
pRS314-NLS-ProtA-Arc1. To create plasmids pRS314-NLS-GFP car-
rying either the full length Arc1 or its truncated mutants, GFP-tagged
Arc1 and the deletion mutants Arc1N(D134–372), Arc1DN1(D7–32),
Arc1DC(D212–372) and Arc1C(D7–198) were excised from the corre-
sponding pASZ11-PNOP1-GFP plasmids [12] as SphI fragments and in-
serted into plasmid pRS314-NLS-ProtA-Arc1 (SphI). For plasmid
pASZ11-PNOP1-GFP-Sub2-Arc1, GFP-Sub2 was ampliﬁed as SphI/
NsiI fragment from plasmid pPNOP1-GFPA1A-Sub2, while plasmid
pASZ11-PNOP1-GFP-Arc1 was opened at the PstI and SphI sites and
the released Arc1 as well as the GFP-Sub2 fragments were inserted
by triple ligation into the pASZ11-PNOP1 vector.
2.3. Construction of double-deletion strains
The construction of strains carrying deletions of the chromosomal
genes coding for MetRS and GluRS (mes1 and gus1, respectively)
was described previously [12]. To construct a double-deletion strain,
the mes1 (mes1::his5+) strain complemented by the plasmid
pRS314-MetRSDN was mated with strain gus1 (gus1::his5+) res-
cued by the plasmid pURA3-GluRS. Diploid cells were allowed to
sporulate and tetrads were dissected. Haploid cells that were HIS+
and sensitive to 5-FOA, were selected as double disrupted mutants
and their genotype was conﬁrmed by PCR. The pURA3-GluRS
plasmid was then shuﬄed out and replaced by a plasmid expressing
the truncated GluRSDN protein. The double-deletion strain arc1
sub2 was created by mating the sub2 (Sub2::kanMX4) strain com-
plemented by a pURA-Sub2 plasmid with the arc1 (arc1::his3+)
strain. Diploid cells were transferred to sporulation medium. After
tetrad dissection, haploid cells that were kanr and sensitive to 5-
FOA were selected as double-deleted mutants and their genotype
was conﬁrmed by PCR.
2.4. Leptomycin B treatment of leptomycin B-sensitive yeast
Yeast cells expressing the XPO1 wild-type allele or the leptomycin B
(LMB)-sensitive xpo1-T539C point mutant allele (strains MNY7 and
MNY8, respectively; [20]) were transformed with pRS314-NLS-GFP-
Arc1p. After growth to an OD600 of 0.6, 10 ml was spun down and
resuspended in 1 ml medium, and 10 ll of 10 lg/ml LMB [26] in etha-
nol was added. Cells were incubated for various times at 30 C before
microscopic inspection.2.5. Miscellaneous procedures
Expression of the fusion proteins transformed in yeast cells was
checked by Western blotting of whole cell extracts using polyclonal
antibodies against the GFP moiety (Clontech). Aﬃnity-puriﬁcation
of ProtA-fusion proteins were performed essentially as described pre-
viously [11,13]. Fluorescence and confocal laser scanning microscopy
was performed as described [12]. SDS–PAGE and DNAmanipulations
(restriction digests, PCR ampliﬁcations, etc.) were performed accord-
ing to standard protocols.3. Results
3.1. Arc1p contains a signal that mediates nuclear exclusion
The Arc1p–MetRS–GluRS complex is formed through
interaction of the N-terminal domain of Arc1p with the N-
terminal appended domains of MetRS and GluRS [12,13].
Removal of these domains caused dissociation of the complex
and nuclear entry of MetRS and GluRS that are normally ex-
cluded from the nucleus [12]. Thus, we concluded that com-
plex formation between Arc1p, MetRS and GluRS is
crucial for nuclear exclusion of the Arc1p–MetRS–GluRS
complex [12]. To further study the mechanism of cytoplasmic
retention of the Arc1p–MetRS–GluRS complex, we analyzed
in vivo the location of Arc1p under conditions that eliminate
its interaction with the aminoacyl-tRNA synthetases. Hence,
we constructed a yeast strain in which the amino-terminally
appended domains of MetRS and GluRS were deleted (see
Section 2). This strain (MetRSDN/GluRSDN) expressing
MetRSDN (lacking amino acids 11–186) and GluRSDN
(lacking amino acids 9–191) was viable with no apparent
growth diﬀerence when compared to a wild-type strain (data
not shown) conﬁrming that the non-catalytic domains of
MetRS and GluRS are dispensable for cell growth [12]. When
ProtA-tagged Arc1p was aﬃnity-puriﬁed from the
MetRSDN/GluRSDN strain, neither of the two enzymes co-
puriﬁed with Arc1p (Fig. 1A) conﬁrming that the association
of Arc1p with the two enzymes is completely impaired in the
absence of their amino-terminal appended domains. We then
examined the intracellular location of GFP-tagged Arc1p in
the MetRSDN/GluRSDN strain. Our results show that Arc1p,
which under these conditions binds to neither MetRS nor
GluRS, is excluded from the nucleus (Fig. 1B). In contrast,
we have previously shown that mutant forms of Arc1p that
lack the N-terminal domain (e.g., Arc1DN lacking amino
acids 7–122) and are, therefore, unable to associate with
MetRS and GluRS can enter the nucleus [12]. Taken together
these ﬁndings suggest that full-length Arc1p is excluded from
the nucleus and this exclusion requires the N-terminal do-
main of Arc1p but is independent of its interaction with
the two aminoacyl-tRNA synthetases.
3.2. Arc1p remains cytoplasmic even when fused to a strong
nuclear localization sequence
To test whether Arc1p has sequence motifs that can mediate
nuclear exclusion through a nuclear export-dependent mecha-
nism, we fused full-length Arc1p or deletion constructs tagged
with GFP to a strong NLS derived from the ribosomal protein
Rpl25p [27] and veriﬁed their stable expression by Western
analysis (Fig. 2A and data not shown). Notably, Arc1p
carrying the strong NLS of Rpl25p was functional since it
complemented the arc1los1 strain (Fig. 2B). Moreover, both
NLS-Arc1DN(D7–122) and NLS-Arc1N(D134–372) could
Fig. 2. Arc1p and its mutant forms are stably expressed and remain
functional when fused to an ectopic NLS. (A) Western blotting
analysis of extracts from arc1 cells expressing GFP-tagged full-length
Arc1p or truncated forms (Arc1DN and Arc1N) fused to the NLS
sequence of Rpl25p, using an anti-GFP antibody. Equal amounts of
extracts were loaded in each lane. The numbers on the left indicate the
position of molecular weight markers. (B) The double disruption
mutant arc1 los1 can be complemented with plasmids expressing
either the full length or truncation mutants of GFP-tagged Arc1p fused
to the NLS sequence of Rpl25p. In the cases of NLS-Arc1DN and
NLS-Arc1N, the N-domain and Arc1DN, respectively, have to be
provided by a diﬀerent plasmid in order to achieve trans-complemen-
tation as previously described for the untagged proteins [13]. Comple-
mentation is shown by the ability to lose the pURA3-Los1 plasmid and
grow in the presence of 5-FOA.
Fig. 1. In the absence of the amino-terminal domains of MetRS and
GluRS, Arc1p is free from the complex but remains in the cytoplasm.
(A) Arc1p interacts with neither MetRS nor GluRS when their amino-
terminal domains are deleted. IgG-Sepharose aﬃnity puriﬁcation of
ProtA-tagged Arc1p expressed in the wild type RS453 strain (lane 1) or
in the mes1gus1 expressing the MetRSDN and GFP-GluRSDN
truncated mutants. (lane 2). Lane M: molecular weight markers (10
kDa ladder; 30–120 kDa). Samples were analyzed by SDS–PAGE and
Coomassie staining. (B) Localization by ﬂuorescence microscopy of
GFP-Arc1 in mes1gus1 cells complemented by plasmids carrying
MetRSDN and ProtA-GluRSDN amino-terminal truncation mutants.
DAPI was used to stain the nuclei, the position of which is indicated by
an arrow.
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sion was combined with the expression of Arc1-N and Arc1-
DN, respectively. Trans-complementation has been previously
shown for their non-tagged counterparts that lacked the ecto-
pic NLS [13]. We then examined the localization of the various
Arc1-GFP-NLS constructs by ﬂuorescence and confocal
microscopy in the MetRSDN/GluRSDN strain (Fig. 3). When
the NLS was fused to Arc1C(D7–198), a strong nuclear accu-
mulation was observed (Fig. 3, panel e). In contrast, when
full-length Arc1p was ﬁtted with the NLS, it remained in the
cytoplasm with a distinct nuclear exclusion (Fig. 3, panels a
and a 0). A mixed phenotype was observed for Arc1DC(212–
372) fused to the NLS, which could enter the nucleus, but also
exhibited a signiﬁcant cytoplasmic location (Fig. 3, panels d
and d 0). In contrast, Arc1N fused to the NLS considerably
accumulated inside the nucleus (Fig. 3, panels b and d). Dele-
tion of the whole N-terminal domain or of just the ﬁrst 32 ami-
no acids of Arc1p (NLS-GFP-Arc1DN1) abolished nuclear
exclusion and induced, instead, strong intranuclear accumula-
tion (Fig. 3, panel c and data not shown). These data show that
the very N-terminal part and, to a lesser extent, the C-terminal
domain of Arc1p are required for nuclear exclusion. Neither of
them is, however, suﬃcient to produce this eﬀect indepen-
dently. These data suggest that the nuclear exclusion of freeArc1p is mediated by complex motifs and requires the struc-
tural integrity of the protein.
3.3. Nuclear exclusion of Arc1p requires the nuclear export
receptor Xpo1p
The nuclear exclusion of Arc1p can be due to cytoplasmic
retention (e.g., by tethering to a cytoplasmic structure) or eﬃ-
cient nuclear export. To test the second possibility, NLS-
GFP-Arc1p was expressed in the xpo1-1 strain that carries
a temperature-sensitive mutation in Xpo1p/exportin 1, the
general nuclear export receptor for NES-containing proteins
[22]. At permissive temperature (23 C), NLS-GFP-Arc1p
was localized in the cytoplasm and excluded from the nucleus
(Fig. 4A, panel a). However, after 1 and 2 h shift to the
restrictive temperature (37 C), NLS-GFP-Arc1p exhibited a
strong accumulation inside the nucleus (Fig. 4A, panels b
and c). Moreover, the location of NLS-GFP-Arc1p was
tested in the LMB-sensitive xpo1 strain [20]. Apparently,
LMB-sensitive cells showed a nuclear accumulation of
NLS-GFP-Arc1p 10 min after LMB addition (Fig. 4B). Ta-
ken together, the data suggest that NLS-Arc1p is excluded
from the nucleus by a mechanism that requires the Xpo1 ex-
port receptor.
Fig. 4. (A) NLS-GFP-Arc1p accumulates inside the nucleus when
Xpo1p is defective. NLS-GFP-tagged full length Arc1p was expressed
in the xpo1-1 mutant strain. Cells were shifted from the permissive
(23 C) to the restrictive (37 C) temperature for 1 or 2 h and the
localization of the protein was checked by ﬂuorescence microscopy.
(B) Addition of LMB to a leptomycin-sensitive strain causes nuclear
accumulation of NLS-GFP-Arc1p. Localization of NLS-GFP-tagged
full length Arc1p by ﬂuorescence microscopy in the leptomycin
sensitive strain before (0 min) and after the addition of LMB in the
culture medium for 10 and 20 min.
Fig. 3. In the absence of an interaction with MetRS and GluRS, the
Arc1p deletion forms containing an ectopic NLS accumulate inside the
nucleus, except full length Arc1p. Localization by ﬂuorescence
microscopy (middle column) of NLS-GFP-Arc1p, NLS-GFP-Arc1N,
NLS-GFP-Arc1DN1, NLS-GFP-Arc1DC and NLS-GFP-Arc1C in the
mes1 gus1 strain complemented by MetRSDN and ProtA-GluRSDN
expressing plasmids. Panels on the left column illustrate representative
cells (sections approximately at the middle of the cells) inspected by
confocal laser microscopy in the corresponding strains; v indicates the
vacuoles and arrows point to the nuclei.
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fused to Arc1p
To ﬁnd out how eﬃciently Arc1p can be exported from the
nucleus, we fused to it the essential nuclear protein Sub2p [23]
(Fig. 5A). As shown byWestern, GFP-Sub2p-Arc1p was stably
expressed (Fig. 5B) and could complement the synthetic lethal
phenotype of the otherwise non-viable arc1los1 strain (Fig.
5C). However, GFP-Sub2p-Arc1p was not able to rescue the
lethal sub2 mutant (Fig. 5C). Consistent with the complemen-
tation data, GFP-Sub2p-Arc1p was located in the cytoplasm
with strong nuclear exclusion, whereas GFP-Sub2p alone
strongly accumulated inside the nucleus (Fig. 5D). These data
further support the view that Arc1p is actively exported from
the nucleus, and can even mislocalize an essential nuclear pro-
tein to the cytoplasm, overriding the function of a strong NLS.4. Discussion
A stable complex between Arc1p and two aminoacyl-tRNA
synthetases, GluRS and MetRS, is formed by the interactionsbetween the amino-terminally appended domains of the en-
zymes and the N-domain of Arc1p [12,14]. One role of this
complex is to increase the aﬃnity for the cognate tRNAs
[13,14]. Moreover, the complex regulates the steady-state dis-
tribution of the components by causing their nuclear exclusion
[12]. In this work, we add another point of insight and show
that Arc1p can be exported from the nucleus in an Xpo1p-
dependent way.
Our previous work showed that free MetRS and GluRS (i.e.,
not bound to Arc1p) can enter the nucleus [12]. Moreover, dis-
tinct domains of Arc1, bigger than the diﬀusion limit of the nu-
clear pore complex, can also enter the nucleus when not
associated with the synthetases and thus must contain a func-
tional NLS [12]. In contrast, we now show that free and full-
length Arc1p remains located in the cytoplasm and is excluded
from the nucleus. Moreover, free Arc1p resisted nuclear im-
Fig. 5. (A) Representation of the GFP-Sub2-Arc1p chimeric protein.
The Sub2 encoding open reading frame (ORF) was fused in frame
between the GFP tag and the Arc1p ORF. Expression of the chimeric
protein is under the control of the NOP promoter. (B) The GFP-Sub2-
Arc1p fusion protein is stably expressed. Western blotting analysis of
extracts from cells expressing GFP-Sub2-Arc1p or GFP-Sub2 using
anti-GFP antibody as indicated. The numbers on the right indicate the
position of molecular weight markers. (C) GFP-Sub2-Arc1p can
complement the arc1 los1 but not the sub2 mutant strain. Upper
panel: The arc1 los1 strain can be complemented by GFP-Arc1p as
well as GFP-Sub2-Arc1p but not GFP-Sub2. Lower panel: The sub2
strain can be complemented by GFP-Sub2 but not by GFP-Sub2-
Arc1p. Complementation is shown by the ability to lose the pURA-
Los1 (upper panel) or the pURA-Sub2 (lower panel) plasmids and
grow in the presence of 5-FOA. (D) Fusion of Sub2p to Arc1p causes
complete mislocalization to the cytoplasm. Localization by ﬂuores-
cence microscopy of GFP-Sub2-Arc1p and GFP-Sub2 in the sub2
arc1 strain complemented by a Sub2p expressing plasmid.
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location of Arc1p seems to be due to eﬃcient nuclear export.
Consistent with this possibility, NLS-Arc1p accumulates inside
the nucleus in xpo1 mutants, which are impaired in NES-
dependent nuclear export of proteins.
Arc1p does not contain a typical leucine-rich NES, which is
the usual motif for Xpo1p-dependent nuclear export [28]. In-
deed, it was not possible to attribute the nuclear exclusion
activity of Arc1 to a short sequence. Our results show that nu-
clear exclusion of Arc1p involves both its N-terminal sequence
(amino acids 1–32) and its C-terminal domain (amino acids
212–372). Two alternative models can explain these data.
According to the ﬁrst model, the parts of Arc1p required for
nuclear exclusion constitute an atypical complex NES. A sim-
ilar case has been shown for snurportin 1, the adaptor for im-port of m3G-capped U snRNPs. Snurportin 1 exhibits a
complex NES that could not be deﬁned by deletion analysis,
despite its strong interaction with and nuclear export by the
mammalian homologue of Xpo1p, CRM1 [29].
According to the second model, the N-terminal part and/or
the C-terminal domain of Arc1p contain cytosolic tethering
functions and a potential nuclear export motif is found else-
where in the structure of Arc1p. This model could explain
why Arc1p without a strong ectopic NLS does not accumulate
inside the nucleus of Xpo1p defective cells (data not shown).
The cytosolic tethering function may be provided by the inter-
action with abundant cytoplasmic translation factors, such as
EF-1b and EF-1c that contain the conserved motif also pres-
ent in the N-terminal domain of Arc1p [12], or with the abun-
dant cytoplasmic tRNA via the TRBD in the C-terminal
Arc1p domain. Finally, the association of Arc1p with Xpo1p
could also be indirect, through an adaptor protein as is the
case for the interaction between CRM1 and the nuclear cap-
binding complex CBC [30].
Taken together, the results from this study and our earlier
work suggest that MetRS, GluRS and Arc1 are shuttling pro-
teins. Why would factors of the tRNA-aminoacylation
machinery need to enter the nucleus at all? It appears that
the extent of nuclear localization of both free MetRS and
GluRS as well as of Arc1p mutants lacking the N-domain is
moderate [12]. The reason for that may be a combination of
weak NLSs with strong NESs. Alternatively, as discussed
above for Arc1p, cytosolic tethering may simply keep the bulk
of these proteins excluded from the nucleus. The small nuclear
fraction of Arc1p and the two synthetases could be necessary
for charging the newly synthesized cognate tRNAs, since
aminoacylation facilitates nuclear tRNA export [2,4,31,32]. In-
deed, mutations that reduce the nuclear pool of tyrosyl-tRNA
synthetase have been shown to impair nuclear export of the
cognate tRNA [6].
Intranuclear aminoacylation of tRNAs is thought to be an
important proof-reading mechanism that will promote the
transport of correctly folded and mature tRNAs to the cyto-
plasm [33]. It is also possible that components of the protein
synthesis machinery may be directly involved in the nuclear ex-
port of aminoacylated tRNA. In fact, the essential translation
elongation factor, eEF1A, has been implicated in the export of
tRNA both in yeast and in vertebrates [34–36]. Our results
showing the active nuclear export of Arc1p raise the interesting
possibility that Arc1p alone or in the Arc1p-complex may be
also involved in facilitating transport of tRNAs from the nu-
cleus to the cytoplasm. This could very well explain the syn-
thetic lethality relationship between Arc1p and the yeast
nuclear tRNA export receptor Los1p [11,17]. Therefore, Arc1p
may be a component of the Los1p-independent but aminoacy-
lation-dependent nuclear tRNA export mechanism that is
known to operate in yeast and possibly in vertebrates
[33,37,38].
The fact that very little Arc1p is allowed at steady-state in-
side the nucleus (due to either weak nuclear import or cytosolic
tethering in combination with nuclear export) may actually re-
ﬂect a subcellular distribution that best serves the cell. It en-
sures that the bulk of the protein is in the cytoplasm to
accomplish its essential task in aminoacylation, with only a
minor pool shuttling between nucleus and cytoplasm to serve
its potential nuclear or nuclear export function. Additionally,
eﬃcient nuclear export of Arc1p as well as other protein
974 K. Galani et al. / FEBS Letters 579 (2005) 969–975translation factors may actually be a way to keep the transla-
tion process strictly cytoplasmic.
Despite the fact that reports have been published claiming
that translation can also occur inside the nucleus [39–41], the
issue of intranuclear translation is strongly debated in the liter-
ature [42–44]. The demonstration that several mammalian
translation factors are excluded from the nucleus by active nu-
clear export [35] decreases the likelihood of a functional nucle-
ar translation apparatus. In particular, initiation factors eIF2B
and eIF5 as well as the termination factor eRF1 have been
shown to be CRM1 export substrates and a nuclear pool of
these proteins could only be observed when inhibition of
CRM1 was combined with their fusion to an ectopic NLS
[35]. The fact that we observe the same for Arc1p in yeast
may indicate the operation of a conserved mechanism that re-
stricts the nuclear concentration of protein translation factors
below the practical level required for protein synthesis.
Finally, we have shown that fusion of Arc1p to the nuclear
protein Sub2p inhibits its function by mislocalizing it to the
cytoplasm. Mutations in Arc1p, itself, or in other cellular com-
ponents that impair the nuclear exclusion of Arc1p should re-
store the essential function of the chimeric Sub2p-Arc1p
protein. Therefore, this chimera could be used as a tool to
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